Trial reportMedicine2026
Efficacy of Kinesio tape for central facial paralysis: A prospective, randomized sham-controlled, single-blinded clinical trial.
Trial report in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTo evaluate the safety and efficacy of Kinesio tape (KT) for managing central facial paralysis (CFP) in adults.
methodsIn this randomized single-blind clinical trial, 121 patients with a 1st stroke event between June 2023 and September 2024 were randomly assigned to 1 of 3 groups (1:1:1 ratio): stimulated group (SG, KT + routine rehabilitation), sham stimulated group (SSG, KT with no tension applied + routine rehabilitation), and control group (CG, routine rehabilitation without KT). All 3 groups received routine rehabilitation therapy, with SG and SSG receiving additional KT treatment. The treatment lasted for 4 weeks, followed by a 4-week follow-up period. House-Brackmann grading scale score, Sunnybrook facial grading system, Burres-Fisch system, facial disability index, functional oral intake scale, and food residue condition were assessed at baseline (T0), after 4 weeks (T1), and 8 weeks (T2).
resultsAt T1, all groups showed significant improvements in House-Brackmann grading scale, Sunnybrook facial grading system, Burres-Fisch , facial disability index, and functional oral intake scale scores versus T0 (P < .05). The SG demonstrated superior therapeutic gains across all metrics except FOIS compared to SSG/CG (effect size: 1.15-2.90, P < .001), with benefits sustained through T2 (T1 vs T2 within SG: P > .05). Moreover, SG showed superior oral-phase efficacy (67.5% vs 45.0%/35.0% food residue condition level 0, P < .05). No significant differences emerged between SSG and CG at any timepoint (P > .05). No serious adverse events were reported.
conclusionOur study demonstrates that tension-applied KT (25%-50% stretch) significantly improves facial symmetry (static/dynamic) and swallowing efficiency in CFP, with sustained benefits ≥4 weeks. Superior to SSG/CG, KT proves a safe adjunct therapy, enhancing motor function and quality of life in CFP rehabilitation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.